This is a $9,771.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems....
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,015.94, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of October 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,858.83, is for the supply of Ozempic, a 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
This is a $17,403.14 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a performance period ending on September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,839.88 firm fixed price contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a period of performance through November 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,644.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,966.25, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a type of prescription medication. The contract has a firm fixed-price pricing type and an ultimate completion date of September 13, 2024. Amerisourcebergen, a large pharmaceutical distributor, has been awarded numerous federal contracts by...
This is a $7,279.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,652.65 firm-fixed price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support...